Cobaugh Christian

Wave Biotech LLC develops and manufactures process equipment for the pharmaceutical and biotechnology industry. The company was founded in 1998 by Vijay Singh and is headquartered in Somerset, NJ

Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH.

RoosterBio, Inc. provides standardized stem cell platforms that enable clinical and commercial translation. Its products include bioprocess media, plug and play systems, clinical control, and roosterbio swag products. The company was founded Jon A. Rowley in 2013 and is headquartered in Frederick, MD.

Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA.

AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark.

AGC Biologics, Inc. develops therapeutic proteins for early clinical trials. The firm offers integrated cGMP manufacturing services using microbial fermentation and mammalian cell culture processes. The company was founded in 2007 and is headquartered in Bothell, WA.

Part of Bayer AG, Bayer HealthCare is a company that provides medical care and animal health care services. The company is based in Tarrytown, NY.

FloDesign Sonics, Inc. provides acoustic technology for separations and filtrations. It develops technology that sound vibrations to filter fluids including blood. The firm also develops filter-less acoustophoretic separation technology, and separate multiple types of particles of varying sizes including water and oil, blood cells, CHO cells, emulsified oils, algae, metals, and bacteria. The company was founded by Bart Lipkens, Stanley Kowalski III, Walter Presz and Louis Masi in 2009 and is headquartered in Wilbraham, MA.

Avitide, Inc. develops affinity purification solutions. Its technology enables development of chromatography resins via chemical synthesis which are not based on costly recombinant proteins. The company was founded by Errik B. Anderson, Warren Kett, Tillman U. Gerngross, Kevin Isett and Jonathan Sheller in 2012 and is headquartered in Lebanon, NH.

ClutchRetail, Inc. provides an internet website portal connecting shoppers with retailers. It enables users to find a product; set a desired price and see the product price change over time; and get an email when price drops below their desired price. The firm also provides price updates and graphs of products that are selected by users; and share useful collections to help friends. The company was founded by Abe Gurjal, Greg A. Kimball and Nathan A. Sharp in 2012 and is headquartered in Boston, MA.

Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium.

Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.

Ulysses Diversified Holdings LLC functions as an investment fund.

Alpenglow Biosciences, Inc. engages in the development and production of three-dimensional open-top light-sheet microscope for the improvement of conducting pathology. The company was founded by Steven Buckley, Adam Glaser, Jonathan Liu, Nicholas Reder, and Larry True in 2018 and is headquartered in Seattle, WA.

Curi Bio, Inc. is engaged in providing drug development services. The company was founded by Elliot Fisher and Deol-Ho Kim and is headquartered in Seattle, WA.

CellFE, Inc. develops delivery platform to enable engineering of life-saving therapies. The company was founded by Anna Liu and Alla Zamarayeva in 2018 and is headquartered in San Carlos, CA.

Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation.

Mytide Therapeutics, Inc. is a peptide and biopolymer manufacturing and computational biology company based in Massachusetts. Mytide's focus is on eliminating the time-consuming and labor-intensive chemical and screening processes that prevent innovative therapeutics from reaching the clinic. The American company's quick-turn manufacturing technology, combined with AI-enabled predictive analytics, provides access to a novel peptide space for the discovery and therapeutic manufacturing of difficult-to-make natural and non-natural peptide and peptide conjugates. The company was founded by Dale Thomas and has been led by CEO Martina Diekmann since 2023.

Lucid Scientific, Inc. provides technology services. The company is headquartered in Atlanta, GA.

SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023.

Wheeler Bio, Inc. is a biomanufacturing company based in the biomanufacturing metro of Oklahoma City, OK. Wheeler Bio's technology platform, Portable CMC™, simplifies the path between drug discovery and clinical manufacturing, providing a new bridge for translating discoveries to first-in-human trials. The company's hub-and-spoke operational model, integrated with biotechs and discovery CROs, revolutionizes the speed of drug development. Wheeler Bio offers a different CDMO model to help innovators go faster with candidates, accelerating processes for plasmids, cell lines, characterization, and more. The company's biologics CDMO facility offers protein expression, cell line development, process development, analytical development, and material supply and testing capabilities. The company was founded by a team of industry experts and strategic investors, led by Jesse McCool who has been the CEO since incorporation.

Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018.

Part of Ncardia SA, Cellistic is a subsidiary that specializes in the process development and manufacture of cell therapies based on human induced pluripotent stem cell (iPSC) technology. The Belgian company's focus and expertise in iPSC reprogramming, differentiation, and expansion protocol development make it an ideal partner for innovative cell therapy developers to commercialize novel advanced therapies. The company was founded by Stefan Braam, and Gustavo Mahler has been the CEO of the company since 2023.